SPS
GH icon

Susquehanna Portfolio Strategies’s Guardant Health GH Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.3M Buy
155,346
+46,867
+43% +$5.1M 0.37% 68
2026
Q1 		$10M Hold
108,479
– – 0.15% 184
2025
Q4 		$11.1M Hold
108,479
– – 0.17% 171
2025
Q3 		$6.78M Buy
+108,479
New +$5.9M 0.11% 254

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Susquehanna Portfolio Strategies's GH Position: Q2 2026 in Review

Susquehanna Portfolio Strategies increased its Guardant Health (GH) stake by 43% in Q2 2026, buying an estimated $5.1M and bringing the position to 155,346 shares worth $23.3M. The position accounts for 0.37% of the portfolio, ranked #68.

Susquehanna Portfolio Strategies first reported a position in GH in Q3 2025 and has held it in 4 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Susquehanna Portfolio Strategies held 155,346 shares of Guardant Health worth $23.3M as of Q2 2026.
  • Susquehanna Portfolio Strategies bought 46,867 Guardant Health shares in Q2 2026, an estimated $5.1M.
  • Guardant Health made up 0.37% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #68 holding.
  • Susquehanna Portfolio Strategies first reported a position in Guardant Health in Q3 2025 and has held it in 4 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.